PRESS-RELEASE ·Filed Nov 16, 2026
Press release · Earnings
TRAW drugs
TRAW drug pipeline →Price Chart
Loading chart...
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3404170 |
Track record
29 reports on TRAW
10 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +72.58% at T+60 after the May 8, 2026 report. 14 of 15 went positive at some point.
Filters
- Nov 16, 2026today Press Release Neutral 4/10 Viewing Entry price pending
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
- Nov 13, 20263d ago EFFECT Bearish 7/10 Entry $0.2510 Now $0.2600 −3.59% settles Dec 14
- Nov 12, 20264d ago 8-K Neutral 4/10 Entry $0.2848 Now $0.2600 −8.71% settles Dec 11
- Oct 26, 202621d ago S-1 Bearish 6/10 Entry $0.3660 Now $0.2600 +28.96% settles Nov 24
- Oct 23, 202624d ago 8-K Bearish 7/10 Entry $0.3411 Now $0.2600 +23.78% settles Nov 23
- Oct 20, 202627d ago DEFA14A Neutral 3/10 Entry $0.3760 Now $0.2600 −30.85% settles Nov 18
- Oct 20, 202627d ago DEF 14A Bearish 6/10 Entry $0.3760 Now $0.2600 +30.85% settles Nov 18
- Aug 14, 202613w ago Press Release Bearish 5/10 Entry $0.5400 to $0.5200 Now $0.2600 +51.85% ▲ +3.70% +2.18% vs SPY
- Jul 10, 202618w ago 8-K Bearish 6/10 Entry $0.6849 to $0.5400 Now $0.2600 +62.04% ▲ +21.16% +24.34% vs SPY
Showing 10 of 29
US Market Status
Market Closed · Opens Wed (10h 45m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers